strongly demonstrated, and high expression of TUBB3 always exists as well as high expression of STMN1 (P=0.006). Meanwhile mutation of EGFR E21 is negatively correlated with TUBB3, and wild type of EGFR E21 always exists toghther with high expression of TUBB3 (P=0.004,6), whereas mutation of KRAS E2 is positively associated with expression level of STMN1 (P=0.038,6). Conclusion Antimicrotubule drug resistance factors of TUBB3 and STMN1 may be related with mutations of EGFR signal pathway, suggesting that EGFR mutation and KRAS mutation may be important factors in regulation of TUBB3/ STMN1 expression, which provided basic references for chemotherapeutic resistance. 和吉西他滨耐药因子R R M1 [4 -6] 。抗微管因子T U BB3和 STMN1是长春新碱、紫杉类、多西他赛等化疗药物的主要 耐药因子，这些耐药因子与化疗药物的关系已经阐明 [7, 8] www.lungca.org 
（T U B B 3）、S t a t h m i n 1（S T M N 1）、胸 苷 酸 合成 酶 （TYMS）、 与NSCLC的化疗疗效直接相关

